chlorambucil has been researched along with Dermatosclerosis in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, BM | 1 |
| Nasseh, GA | 1 |
| Bywaters, EG | 1 |
| Tulliez, M | 1 |
| Ricard, MF | 1 |
| Jan, F | 1 |
| Sultan, C | 1 |
2 other studies available for chlorambucil and Dermatosclerosis
| Article | Year |
|---|---|
Scleroderma in childhood.
Topics: Adolescent; Age Factors; Arthritis, Juvenile; Bone Diseases; Child; Chlorambucil; Diagnosis, Differe | 1976 |
Preleukaemic abnormal myelopoiesis induced by chlorambucil: a case study.
Topics: Anemia, Sideroblastic; Blood Platelets; Bone Marrow; Chlorambucil; Female; Humans; Leukemia, Myeloid | 1974 |